Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2889 results

Sort By:

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Study ID: NCT07374029
Start Date: 2026-07
End Date: 2030-10-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

DC/AML Fusion Vaccine

T-Cell Therapy

Decitabine

Venetoclax

GM-CSF

Sponsor

David Avigan

Source: clinicaltrials.gov

Share:
Add to list

Person-Centred AI Support in Interdisciplinary Rehabilitation for Chronic Pain

Study ID: NCT07081737
Start Date: 2026-05-01
End Date: 2029-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Interdisciplinary treatment (IDT) + Clinical Decision Support System (CDSS)

Interdisciplinary treatment (IDT)

Sponsor

Bjorn The

Source: clinicaltrials.gov

Share:
Add to list

EEG-Guided Analgesic Titration During General Anesthesia to Improve Early Neurocognitive Recovery in Older Patients

Study ID: NCT04443517
Start Date: 2026-04-01
End Date: 2031-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

Alpha Optimization

Emergence from anesthesia with Dexmedetomidine

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

Study ID: NCT07387094
Start Date: 2026-03-03
End Date: 2027-12-16
Study Type

Interventional

Study Phase

Phase3

No. of Participants

140

Intervention / Treatment

XW003 injection

placebo with matching volume

Sponsor

Hangzhou Sciwind Biosciences Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification (Ro-SjS)

Study ID: NCT07414667
Start Date: 2026-06-01
End Date: 2028-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment
Sponsor

Central Hospital, Nancy, France

Source: clinicaltrials.gov

Share:
Add to list

Vitality in Infants Via Azithromycin for Neonates Trial

Study ID: NCT05763693
Start Date: 2026-04
End Date: 2030-04
Study Type

Interventional

Study Phase

Phase4

No. of Participants

4000

Intervention / Treatment

Azithromycin at Baseline

Azithromycin at Day 21

Placebo at Baseline

Placebo at Day 21

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

A Phase I Study of PepGNP-ChikV in Healthy Volunteers

Study ID: NCT07394426
Start Date: 2026-08-03
End Date: 2028-05-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

40

Intervention / Treatment

PepGNP-ChikV

Placebo

Sponsor

Gylden Pharma Ltd

Source: clinicaltrials.gov

Share:
Add to list

Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study

Study ID: NCT07295821
Start Date: 2026-03-09
End Date: 2029-05-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Osimertinib

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy

Study ID: NCT07408648
Start Date: 2026-04-15
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

244

Intervention / Treatment

hetrombopag 7.5 mg orally once daily

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Source: clinicaltrials.gov

Share:
Add to list

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

Study ID: NCT07220447
Start Date: 2026-04-01
End Date: 2027-07-09
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

50

Intervention / Treatment

Survey Administration

Theanine

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list